🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, global, randomized, open-label, multicenter, study eva...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2021-08-27
Trial ID
NCT04961996
Treatments Being Tested
This phase II trial tests how well pembrolizumab along with standard of car...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-16
Trial ID
NCT06528210
RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, ...
Status
Completed
Location
The Kirklin Clinic at Acton Road
Start Date
2012-05
Trial ID
NCT01546987
Treatments Being Tested
This is a phase II randomized, open-label study comparing salvage radiother...
Status
Unknown
Location
OLVZ Aalst
Start Date
2019-04-05
Trial ID
NCT03899077
A prospective, single-arm phase II study is the individualization of RT for...
Status
Recruiting
Location
German Oncology Center
Start Date
2024-09-16
Trial ID
NCT06582446
The aim of this study is to determine the long term effects of two types of...
Status
Completed
Location
Wirral University Hospitals NHS Trust
Start Date
1999-10
Trial ID
NCT00536653
Non-combat-related muscle, tendon and bone injuries are the most common inj...
Status
Recruiting
Location
Neuromuscular Research Laboratory
Start Date
2024-07-15
Trial ID
NCT06455969
This study will evaluate the efficacy and safety of multiple biomarker-sele...
Status
Active Not Recruiting
Location
UCSF Helen Diller Family CCC
Start Date
2021-10-07
Trial ID
NCT04931342
This adaptive phase II/III randomized trial is designed to demonstrate that...
Status
Active Not Recruiting
Location
BC CANCER Vancouver
Start Date
2016-10
Trial ID
NCT02685397
RATIONALE: Hormones can stimulate the production of prostate cancer cells. ...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2000-01
Trial ID
NCT00004054